Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer
Author:
Funder
Pfizer
AstraZeneca
Eisai Ltd
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference29 articles.
1. Multi-kinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib;Stjepanovic;Biologics,2014
2. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer;Schlumberger;N Engl J Med,2015
3. Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the Phase III SELECT trial;Brose;J Clin Oncol,2017
4. Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer;Suyama;Mol Clin Oncol,2017
5. Incidence and timing of common adverse events in lenvatinib-treated patients from the SELECT trial and their association with survival outcomes;Haddad;Endocrine,2017
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer;Expert Opinion on Pharmacotherapy;2024-08-12
2. Efficacy and Safety of Tyrosine Kinase Inhibitors in Downstaging and Palliation in Patients with Advanced Differentiated Thyroid Cancer — A Multicentre study;Indian Journal of Surgical Oncology;2024-08-09
3. Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice;European Thyroid Journal;2023-07-10
4. Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit;Head and Neck Tumors (HNT);2023-03-09
5. CACA guidelines for holistic integrative management of thyroid cancer;Holistic Integrative Oncology;2022-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3